Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01295970 : Surgery Versus Radiosurgery for the Treatment of Single Brain Metastases
PhaseN/A
AgesMin: 19 Years Max: N/A
Eligibility
Inclusion Criteria:

1. Biopsy proven malignancy (original biopsy is adequate as long as the brain imaging is
consistent with brain metastases)

2. Patients > 18 years

3. A contrast-enhanced MRI demonstrating the presence a single brain metastases <3cm
performed within one month prior to registration

4. Life expectancy > 3 months

5. RPA Class 1 and RPA Class 2 patients with stable primary disease

6. Patients must have normal organ and marrow function

7. Women of child-bearing potential must agree to use adequate contraception (hormonal
or barrier method of birth control; abstinence) prior to study entry and for the
duration of study participation. Should a woman become pregnant or suspect she is
pregnant while participating in this study, she should inform her treating physician
immediately

8. ECOG Performance Status 0-2

9. Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

1. Have tumor(s) in the midbrain, pons, or medulla, in eloquent cortex

2. Have tumors within 10 millimeters of the optic apparatus (nerves and chiasm) or the
area postrema

3. Be poor operative candidates from an anesthetic point of view secondary to other
major medical illnesses

4. Have a coagulopathy demonstrated by an abnormal prothrombin time, activated partial
thromboplastin time, or thrombocytopenia (platelet count less that 150,000
platelets/mm3)

5. Have radiographic or cerebrospinal fluid specimen evidence of widespread
leptomeningeal metastasis

6. Significant psychiatric impairments which, in the opinion of the investigators, will
interfere with the proper administration or completion of the protocol

7. Acute or untreated infections (viral, bacterial or fungal)

8. Be prisoners or other institutionalized individuals

9. Have a diagnosis of germ cell tumor, lymphoma or small cell lung cancer 10.Concurrent
chemotherapy or molecularly targeted anti-cancer therapy

11.Allergy to Gadolinium 12.Imminent brain herniation, massive peritumoural oedema or
hydrocephalus 13.Have any metallic implant that would exclude the possibility of having a
brain MRI
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01295970      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740